Elkfork Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
$1.61M Buy
17,918
+442
+3% +$39.8K 0.04% 303
2019
Q2
$1.48M Buy
17,476
+10,268
+142% +$867K 0.04% 320
2019
Q1
$635K Buy
7,208
+1,700
+31% +$150K 0.02% 498
2018
Q4
$393K Buy
+5,508
New +$393K 0.01% 589